Emmes Welcomes Bryan Patterson As Senior Vice President To Lead Government Initiatives

Emmes® is a lead in a global contract research organisation (CRO) specialising in tech and AI-driven solutions. Today, The organisation announced Bryan Patterson as its new Senior Vice President of Government Business Development & Capture. This newly established role highlights Emmes’ dedication to advancing clinical research initiatives for U.S. Federal Government agencies while driving innovation and exceeding expectations.

Emmes Chief Executive Officer, Peter Ronco, said in a statement, “We’re delighted to welcome Bryan to Emmes at this exciting moment in our evolution. His extensive expertise, strategic vision, and well-established relationships across government agencies make him a tremendous asset to our team. As we continue to modernise and embed AI-driven solutions within clinical research, Bryan’s leadership will be invaluable in delivering greater efficiency, innovation, and value to our government partners.”

Bringing over 14 years of experience in securing clinical research programs and building strategic partnerships with federal agencies, Mr Patterson will lead the expansion of Emmes’ government business portfolio. Reporting to Paul VanVeldhuisen, President of Emmes Public Sector, and serving on the company’s Management Committee. Patterson will also focus on strengthening relationships and delivering cutting-edge solutions for government-sponsored clinical trials.

Mr Bryan Patterson expressed, “I’m honoured to step into this role at a pivotal time for Emmes and the clinical research industry. Combining deep scientific expertise with advanced technology and AI to accelerate medical breakthroughs, Emmes is redefining how government-sponsored clinical research programs are conducted. I look forward to collaborating with our talented team to expand Emmes’ impact and help shape the future of government clinical research.”

Prior to this, Mr Patterson’s experience included leading prominent roles at organisations like PPD and Rho where he effectively equipped the government business portfolios and strengthened collaborative partnerships. His ability to implement innovative strategies aligns perfectly with Emmes’ vision for transformative progress in the clinical research sector.